| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |